Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:LUCDNASDAQ:RCELNASDAQ:SGHTNASDAQ:SPAI On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeLUCDLucid Diagnostics$1.26+1.2%$1.34$0.68▼$1.80$136.32M1.28556,532 shs922,605 shsRCELAVITA Medical$5.86-3.0%$8.01$5.46▼$14.16$154.91M1.74180,455 shs277,934 shsSGHTSight Sciences$4.02+3.3%$2.94$2.03▼$8.45$207.82M2.41214,611 shs343,933 shsSPAISafe Pro Group Inc. Common Stock$2.64-9.0%$2.71$1.47▼$6.50$40.05MN/A707,132 shs15,602 shsFree Today: Your Guide to Smarter Options TradesLearn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceLUCDLucid Diagnostics+1.20%-17.11%-1.95%-6.67%+42.42%RCELAVITA Medical-2.98%-3.46%-36.58%-31.22%-36.37%SGHTSight Sciences+3.34%+16.86%+31.80%+66.12%-42.07%SPAISafe Pro Group Inc. Common Stock-8.97%-2.94%-19.02%-25.21%+263,999,900.00%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationLUCDLucid Diagnostics2.5722 of 5 stars3.63.00.00.02.01.70.6RCELAVITA Medical1.472 of 5 stars3.40.00.00.03.20.00.6SGHTSight Sciences2.2979 of 5 stars2.13.00.00.02.94.20.6SPAISafe Pro Group Inc. Common StockN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceLUCDLucid Diagnostics 3.20Buy$3.50177.78% UpsideRCELAVITA Medical 2.75Moderate Buy$17.25194.37% UpsideSGHTSight Sciences 2.29Hold$4.02-0.08% DownsideSPAISafe Pro Group Inc. Common Stock 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest SPAI, LUCD, RCEL, and SGHT Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/22/2025SGHTSight SciencesCitigroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingNeutral ➝ Neutral$3.20 ➝ $3.605/15/2025LUCDLucid DiagnosticsCantor FitzgeraldSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOverweight ➝ Overweight$2.00 ➝ $2.005/14/2025LUCDLucid DiagnosticsNeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$3.00 ➝ $3.005/9/2025SGHTSight SciencesLake Street CapitalSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetHold ➝ Hold$2.50 ➝ $3.004/21/2025LUCDLucid DiagnosticsAscendiant Capital MarketsSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$7.00 ➝ $7.504/11/2025LUCDLucid DiagnosticsNeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$3.00 ➝ $3.004/10/2025RCELAVITA MedicalD. Boral CapitalSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$22.00 ➝ $22.004/9/2025SGHTSight SciencesNeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingHold ➝ Hold4/4/2025RCELAVITA MedicalD. Boral CapitalSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$22.00 ➝ $22.003/26/2025LUCDLucid DiagnosticsCantor FitzgeraldSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOverweight ➝ Overweight$2.00 ➝ $2.003/25/2025LUCDLucid DiagnosticsBTIG ResearchSubscribe to MarketBeat All Access for the recommendation accuracy ratingSet Price Target$2.00(Data available from 6/4/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookLUCDLucid Diagnostics$4.17M32.67N/AN/A($0.47) per share-2.68RCELAVITA Medical$71.66M2.16N/AN/A$0.17 per share34.47SGHTSight Sciences$78.11M2.66N/AN/A$2.47 per share1.63SPAISafe Pro Group Inc. Common Stock$2.05M19.57N/AN/AN/A∞Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateLUCDLucid Diagnostics-$52.67M-$1.34N/AN/AN/A-1,069.87%N/A-123.54%8/11/2025 (Estimated)RCELAVITA Medical-$61.85M-$2.19N/AN/AN/A-96.26%-337.91%-71.50%8/14/2025 (Estimated)SGHTSight Sciences-$55.55M-$0.98N/AN/AN/A-63.30%-47.28%-32.72%7/30/2025 (Estimated)SPAISafe Pro Group Inc. Common StockN/A-$0.81N/A∞N/AN/AN/AN/A6/27/2025 (Estimated)Latest SPAI, LUCD, RCEL, and SGHT EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/15/2025Q1 2025SPAISafe Pro Group Inc. Common StockN/A-$0.27N/A-$0.27N/A$0.19 million5/8/2025Q1 2025RCELAVITA Medical-$0.39-$0.53-$0.14-$0.53$33.15 million$18.51 million5/8/2025Q1 2025SGHTSight Sciences-$0.29-$0.28+$0.01-$0.28$16.51 million$17.51 million3/28/2025Q4 2024SPAISafe Pro Group Inc. Common StockN/A-$0.06N/A-$0.06N/A$0.89 million3/5/2025Q4 2024SGHTSight Sciences-$0.22-$0.23-$0.01-$0.23$18.98 million$19.07 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthLUCDLucid DiagnosticsN/AN/AN/AN/AN/ARCELAVITA MedicalN/AN/AN/AN/AN/ASGHTSight SciencesN/AN/AN/AN/AN/ASPAISafe Pro Group Inc. Common StockN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioLUCDLucid DiagnosticsN/A1.181.14RCELAVITA Medical9.392.832.47SGHTSight Sciences0.3610.189.74SPAISafe Pro Group Inc. Common StockN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipLUCDLucid Diagnostics74.01%RCELAVITA Medical27.66%SGHTSight Sciences55.51%SPAISafe Pro Group Inc. Common StockN/AInsider OwnershipCompanyInsider OwnershipLUCDLucid Diagnostics6.80%RCELAVITA Medical1.82%SGHTSight Sciences30.90%SPAISafe Pro Group Inc. Common Stock54.80%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableLUCDLucid Diagnostics70108.19 million54.12 millionNo DataRCELAVITA Medical13026.44 million25.74 millionOptionableSGHTSight Sciences21051.70 million36.09 millionOptionableSPAISafe Pro Group Inc. Common Stock1115.17 millionN/AN/ASPAI, LUCD, RCEL, and SGHT HeadlinesRecent News About These CompaniesSafe Pro Group Provides First Quarter 2025 Results and Corporate UpdateMay 15, 2025 | businesswire.comSafe-Pro Awarded Order for Ballistic Protective Gear to Support Demining Operations in the Asia-Pacific RegionMay 12, 2025 | businesswire.comSafe Pro Group Inc. Common Stock (SPAI)May 6, 2025 | nasdaq.comSafe Pro Demonstrates Next-Generation of Military Force Protection Powered by its Artificial Intelligence, Small Object Threat Detection TechnologyMay 1, 2025 | businesswire.comSafe Pro's AI Edge-Based Small Object Threat Detection Platform Demonstrates Effectiveness in Actual Minefield Operations for Military Force Protection and Humanitarian ApplicationsApril 23, 2025 | businesswire.comSafe Pro seeks expansion of U.S. patent for drone imagery technologyApril 22, 2025 | markets.businessinsider.comSafe Pro Seeks International Expansion of US Awarded Patent for its AI-Powered Drone Imagery Technology Through 47 National Phase JurisdictionsApril 21, 2025 | businesswire.comSafe Pro Group Subsidiary Receives Order for Advanced Drone-Based Infrastructure Assessments Under Existing Multi-Year Contract with Major Florida UtilityApril 9, 2025 | businesswire.comSafe Pro Group Subsidiary Receives Order for Advanced Drone-Based Infrastructure Assessments Under Existing Multi-Year Contract with Major Florida UtilityApril 9, 2025 | businesswire.comSafe Pro enters MOU with Ukraine’s Center of ExcellenceApril 8, 2025 | markets.businessinsider.comSafe Pro Group Delivers Explosive Ordnance Imagery Data Set Under Government-Linked Contract, Expanding into New High-Value Revenue StreamApril 8, 2025 | businesswire.comSafe Pro Enters into Strategic Partnership, Signing MOU with Ukraine's National Mine Action Center of Excellence to Modernize Demining with AI-Powered Threat DetectionApril 7, 2025 | businesswire.comWhy Safe Pro Group (SPAI) Declined Last Week?April 1, 2025 | msn.comSafe Pro Group Reports Surging 136% Revenue Growth for FY 2024 Surpassing ExpectationsMarch 31, 2025 | tmcnet.comIs Safe Pro Group Inc. (SPAI) Among the Worst Performing Defense Stocks So Far in 2025?March 31, 2025 | msn.comWhy Safe Pro Group (SPAI) Is Declining This Week?March 11, 2025 | msn.comFmr. Principal Deputy Asst. Secretary of the Army, Young J. Bang, Joins Safe Pro to Advance AI Technology for US Armed ForcesMarch 3, 2025 | businesswire.comSafe Pro Group Inc. (SPAI) Signs MoU with Kyiv Polytechnic for AI-Powered Demining TechFebruary 26, 2025 | msn.comSafe Pro and Kyiv Polytechnic Institute, Ukraine's Leading Technical University, Sign Multi-Year MOU to Collaborate on Artificial Intelligence and Drone TechnologyFebruary 25, 2025 | businesswire.comSafe Pro Group Inc. (SPAI) Achieves Milestone in AI-Powered Explosive Threat Detection in UkraineFebruary 20, 2025 | msn.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeSPAI, LUCD, RCEL, and SGHT Company DescriptionsLucid Diagnostics NASDAQ:LUCD$1.26 +0.02 (+1.20%) Closing price 06/3/2025 04:00 PM EasternExtended Trading$1.30 +0.03 (+2.78%) As of 08:34 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Lucid Diagnostics Inc. operates as a commercial-stage medical diagnostics technology company in the United States. The company focuses on patients with gastroesophageal reflux disease (GERD) who are at risk of developing esophageal precancer and cancer, primarily highly lethal esophageal adenocarcinoma. Its flagship product, the EsoGuard Esophageal DNA Test performed on samples collected with the EsoCheck Esophageal Cell collection device, a testing tool with the goal of preventing EAC deaths through early detection of esophageal precancer in at-risk GERD patients. The company was incorporated in 2018 and is based in New York, New York. Lucid Diagnostics Inc. is a subsidiary of PAVmed Inc.AVITA Medical NASDAQ:RCEL$5.86 -0.18 (-2.98%) Closing price 06/3/2025 04:00 PM EasternExtended Trading$6.26 +0.40 (+6.81%) As of 08:15 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.AVITA Medical, Inc., together with its subsidiaries, operates as a regenerative medicine company in the United States and internationally. The company's lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds, full-thickness skin defects, and repigmentation of stable depigmented vitiligo lesions. It develops RECELL GO to control the manual process of disaggregation, filtration, and soak time. The company was formerly known as AVITA Therapeutics, Inc. AVITA Medical, Inc. was incorporated in 2020 and is headquartered in Valencia, California.Sight Sciences NASDAQ:SGHT$4.02 +0.13 (+3.34%) Closing price 06/3/2025 04:00 PM EasternExtended Trading$4.09 +0.07 (+1.77%) As of 08:00 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Sight Sciences, Inc., an ophthalmic medical device company, engages in the development and commercialization of surgical and nonsurgical technologies for the treatment of eye diseases. It operates through two segments, Surgical Glaucoma and Dry Eye. The company's products include OMNI Surgical System, an implant-free glaucoma surgery technology indicated to reduce intraocular pressure in adult patients with primary open-angle glaucoma; and SION Surgical Instrument, a manually operated device used in ophthalmic surgical procedures to excise trabecular meshwork. It also offers TearCare System, a wearable eyelid technology for adult patients with evaporative dry eye disease due to meibomian gland dysfunction, as well as related components. It offers its products through sales representatives and distributors to hospitals, medical centers, and eyecare professionals in the United States. Sight Sciences, Inc. was incorporated in 2010 and is headquartered in Menlo Park, California.Safe Pro Group Inc. Common Stock NASDAQ:SPAI$2.64 -0.26 (-8.97%) Closing price 06/3/2025 03:59 PM EasternExtended Trading$2.66 +0.01 (+0.57%) As of 06/3/2025 06:27 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Safe Pro Group, Inc. engages in the provision and acquisition of security and protection products. Its products include Artificial Intelligence (AI) and Machine Learning (ML) software technology and photogrammetry analysis tools, bullet and blast resistant personal protection equipment, and aerial managed services and mission-critical uncrewed solutions. The firm operates through the following segments: Safe-PRO USA, Airborne Response, and Safe Pro AI. The company was founded by Daniyel Erdberg on December 15, 2021 and is headquartered in Aventura, FL. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas 3 Reasons Amazon Could Be the Best Tech Performer in June Tesla’s Lofty 200 P/E Could Mean More Upside Ollie’s Q1 Earnings: The Good, the Bad, and What’s Next Applied Digital: CoreWeave’s AI Deal Lights a $7 Billion Fuse Qualcomm: A Technical Deep-Dive Confirms the Worst Rocket Lab Expands Into Payloads: Should You Be Paying Attention? Steel Dynamics Shares Climb After Tariff Announcement Palantir Soars on Government Deals as Valuation Debate Lingers Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
